Kailera Therapeutics has raised an eye-watering $600 million in Series B financing to take its lead drug for weight loss into pivotal trials, in a further sign of the insatiable investor appetite for ...

Vice President JD Vance is headed to Israel on Monday to help push forward the second phase of the historic Gaza peace deal. Vance plans to visit the Holy Land alongside Special Envoy to the Middle ...

JERUSALEM/CAIRO (Reuters) -U.S. Vice President JD Vance was holding talks in Israel on Tuesday as Washington tries to stabilise the first, shaky, phase of the Gaza ceasefire and push Israel and Hamas ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now it can celebrate a key trial win for its first drug to gain an FDA approval in ...

US Vice President JD Vance was holding talks in Israel on Tuesday as Washington tries to stabilise the first, shaky, phase of the Gaza ceasefire and push Israel and Hamas towards the harder ...

Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

Microsoft announced Thursday that it's integrating agentic artificial intelligence into Windows 11, making its Copilot AI software more accessible as a voice or text assistant. In a blog post and ...

On Friday, 17 October, the Indian equity market extended its upward momentum, closing the week on a firm note amid steady global cues and renewed interest across key sectors. The Nifty 50 rose 124.55 ...

The surprise move could give Democrats two or three additional House seats and is likely to scramble the last couple weeks of campaigning ahead of the Nov. 4 election. By Reid J. Epstein Reid J.